Birth size and neonatal levels of major components of the IGF system: Implications for later risk of cancer

Journal of Pediatric Endocrinology and Metabolism

Volumn 15, Issue 9, 2002, Pages 1479-1486

  Skalkidou, A ^a   Petridou, Eleni ^a,b   Papathoma, E ^a   Salvanos, H ^a   Chrousos, G ^a   Trichopoulos, D ^a,b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Birth weight; Insulin like growth factor; Jaundice; Neoplasia; Newborn

Indexed keywords

BILIRUBIN; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ACUTE PHASE RESPONSE; ARTICLE; BILIRUBIN BLOOD LEVEL; BIRTH WEIGHT; BLOOD SAMPLING; BODY GROWTH; BODY HEIGHT; CANCER RISK; CARCINOGENESIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; HUMAN; INFANT; JAUNDICE; LIVER DYSFUNCTION; LIVER FUNCTION; MALE; NEWBORN; NEWBORN PERIOD; PHLEBOTOMY; PREDICTION; PRENATAL GROWTH; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RISK ASSESSMENT; SOCIOECONOMICS;

EID: 0036909019     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2002.15.9.1479     Document Type: Article

References (29)

1. Bambang S, Spencer NJ, Logan S, Gill L. Cause-specific perinatal death rates, birth weight and deprivation in the West Midlands, 1991-93. Child Care Health Dev 2000; 26: 73-82.
2. Pollack MM, Koch MA, Bartel DA, Rapoport I, Dhanireddy R, El-Mohandes AA, Harkavy K, Subramanian KN. A comparison of neonatal mortality risk prediction models in very low birth weight infants. Pediatrics 2000; 105: 1051-1057.
3. Eriksson JG, Forsen T, Tuomilehto J, Osmond C, Barker DJ. Early growth and coronary heart disease in later life: longitudinal study. Br Med J 2001; 322: 949-953.
4. Signorello LB, Trichopoulos D. Perinatal determinants of adult cardiovascular disease and cancer. Scand J Soc Med 1998; 26: 161-165.
5. Ekbom A, Erlandsson G, Hsieh C, Trichopoulos D, Adami HO, Cnattingius S. Risk of breast cancer in prematurely born women. J Natl Cancer Inst 2000; 92: 840-841.
6. Mantzoros CS, Tzonou A, Signorello LB, Stampfer M, Trichopoulos D, Adami HO. Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. Br J Cancer 1997; 76: 1115-1118.
7. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 1998; 279: 563-566.
8. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 1998; 351: 1393-1396.
9. Petridou E, Dessypris N, Spanos E, Mantzoros C, Skalkidou A, Kalmanti M, Koliouskas D, Kosmidis H, Panagiotou JP, Piperopoulou F, Tzortzatou F, Trichopoulos D. Insulin-like growth factor-1 and binding protein-3 in relation to childhood leukaemia. Int J Cancer 1999; 80: 494-496.
10. Manousos O, Souglakos J, Bosetti C, Tzonou A, Chatzidakis V, Trichopoulos D, Adami HO, Mantzoros C. IGF-I and IGF-II in relation to colorectal cancer. Int J Cancer 1999; 83: 15-17.
11. Arends N, Johnston L, Hokken-Koelega A, van Duijn C, de Ridder M, Savage M, Clark A. Polymorphism in the IGF-I gene: clinical relevance for short children born small for gestational age (SGA). J Clin Endocrinol Metab 2002; 87: 2720.
12. Vatten LJ, Nilsen ST, Odegard RA, Romundstad PR, Austgulen R. Insulin-like growth factor I and leptin in umbilical cord plasma and infant birth size at term. Pediatrics 2002; 109: 1131-1135.
13. Vaessen N, Janssen JA, Heutink P, Hofman A, Lamberts SW, Oostra BA, Pols HA, van Duijn CM. Association between genetic variation in the gene for insulin-like growth factor-I and low birthweight. Lancet 2002; 359: 1036-1037.
14. Hernandez-Valencia M, Zarate A, Ochoa R, Fonseca ME, Amato D, De Jesus Ortiz M. Insulin-like growth factor I, epidermal growth factor and transforming growth factor beta expression and their association with intrauterine fetal growth retardation, such as development during human pregnancy. Diabetes Obes Metab 2001; 3: 457-462.
15. Ong K, Kratzsch J, Kiess W, Dunger D, the ALSPAC Study Team. Circulating IGF-I levels in childhood are related to both current body composition and early postnatal growth rate. J Clin Endocrinol Metab 2002; 87: 1041-1044.
16. Diaz E, Halhali A, Luna C, Diaz L, Avila E, Larrea F. Newborn birth weight correlates with placental zinc, umbilical insulin-like growth factor I, and leptin levels in preeclampsia. Arch Med Res 2002; 33: 40-47.
17. Bajoria R, Sooranna SR, Ward S, Hancock M. Placenta as a link between amino acids, insulin-IGF axis, and low birth weight: evidence from twin studies. J Clin Endocrinol Metab 2002; 87: 308-315
18. Christou H, Connors JM, Ziotopoulou M, Hatzidakis V, Papathanassoglou E, Ringer SA, Mantzoros CS. Cord blood leptin and insulin-like growth factor levels are independent predictors of fetal growth. J Clin Endocrinol Metab 2001; 86: 935-938.
19. Vatten LJ, Odegard RA, Nilsen ST, Salvesen KA, Austgulen R. Relationship of insulin-like growth factor-I and insulin-like growth factor binding proteins in umbilical cord plasma to preeclampsia and infant birth weight. Obstet Gynecol 2002; 99: 85-90.
20. Moller S, Juul A, Becker U, Flyvbjerg A, Skakkebaek NE, Henriksen JH. Concentrations, release, and disposal of insulin-like growth factor (IGF)-binding proteins (IGFBP), IGF-I, and growth hormone in different vascular beds in patients with cirrhosis. J Clin Endocrinol Metab 1995; 80: 1148-1157.
21. Davidson S, Shtaif B, Gil-Ad I, Maayan R, Sulkes J, Weizman A, Merlob P. Insulin, insulin-like growth factors-I and -II and insulin-like growth factor binding protein-3 in newborn serum: association with normal fetal head growth and head circumference. J Pediatr Endocrinol Metab 2001; 14: 151-158.
22. Halhali A, Tovar AR, Torres N, Bourges H, Garabedian M, Larrea F. Preeclampsia is associated with low circulating levels of insulin-like growth factor I and 1,25-dihydroxyvitamin D in maternal and umbilical cord compartments. J Clin Endocrinol Metab 2000; 85: 1828-1833.
23. Petridou E, Trichopoulos D, Revinthi K, Tong D, Papathoma E. Modulation of birth weight through gestational age and fetal growth. Child Care Dev 1996; 22: 37-53.
24. Bonellie SR. Effect of maternal age, smoking and deprivation on birthweight. Paediatr Perinat Epidemiol 2001; 15: 19-26.
25. Bardham A. The effect of parity and maternal age on birth weight. J Natl Med Assoc 1966; 58: 194-196.
26. Yeazel MW, Ross JA, Buckley JD, Woods WG, Ruccione K, Robison LL. High birth weight and risk of specific childhood cancers: a report from the Children's Cancer Group. J Pediatr 1997; 131: 671-677.
27. Cnattingius S, Zack MM, Ekbom A, Gunnarskog J, Kreuger A, Linet M, Adami HO. Prenatal and neonatal risk factors for childhood lymphatic leukemia. J Natl Cancer Inst 1995; 87: 908-914.
28. Petridou E, Trichopoulos D, Kalapothaki V, Pourtsidis A, Kogevinas M, Kalmanti M, Koliouskas D, Kosmidis H, Panagiotou JP, Piperopoulou F, Tzortzatou F. The risk profile of childhood leukaemia in Greece: a nationwide case-control study. Br J Cancer 1997; 76: 1241-1247.
29. Michels KB, Trichopoulos D, Robins JM, Rosner BA, Manson JE, Hunter DJ, Colditz GA, Hankinson SE, Speizer FE, Willett WC. Birthweight as a risk factor for breast cancer. Lancet 1996; 348: 1542-1546.